Company Recalls Injectable CBD Products Following FDA Warning Letter

Marijuana Moment
By Kyle JaegerMay 21, 2020, 11:29 am260 pts
A Food and Drug Administration (FDA) letter warning a company about its marketing of injectable CBD products has led to a voluntary recall that the federal agency announced on Wednesday. Biota Biosciences received the letter last month, with FDA directing the firm to cease sales of its line of CBD vials, which…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Canada’s cannabis legalization initiative: Funding, outcomes, and departmental spending 72

How a woman-led biotech firm is advancing cannabis medicine 51

Alberta wholesaled nearly $700 million worth of cannabis in the 2024-2025 fiscal year 14

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.